The DOI matches its Crossref record.
Specific loss of the high-molecular-weight form of S -adenosyl-l-methionine synthetase in human liver cirrhosis
Open accessAbstract
We have measured the activity of S-adenosyl-L-methionine synthetase, the ratio between the high- and low-molecular-weight forms of this enzyme and the concentration of S-adenosyl-L-methionine in liver biopsies from a group of controls (n = 6) and in six cirrhotics (five posthepatitic and one alcoholic). The total activity of S-adenosyl-L-methionine synthetase was markedly reduced in cirrhosis (37.5% of that found in the control group). This was due to a specific reduction in the high-molecular-weight S-adenosyl-L-methionine synthetase in the group of cirrhotics (73.9 pmoles per min per mg protein) when compared with that observed in controls (460.3 pmoles per min per mg protein). Despite this reduction in the rate of synthesis of S-adenosyl-L-methionine (the high-molecular-weight form of the enzyme is 15 times more active than the low-molecular-weight form at physiological concentration of substrates), the concentration of this metabolite was the same in the control group (17.3 ± 2.6 μ M) and in the group of cirrhotics (17.8 ± 3.1 μ M). To explain these findings, it is postulated that in human liver, where the concentration of S-adenosyl-L-methionine is lower than the K m values of a variety of enzymes that use this metabolite (around 50 to 100 μ M), a reduction in the synthesis of S-adenosyl-L-methionine is compensated by a reduction in the rate of utilization of this molecule without affecting the intrahepatic concentration of S-adenosyl-L-methionine. This postulate was tested by decreasing the activity of the high-molecular-weight S-adenosyl-L-methionine synthetase in rat liver by treatment with galac-tosamine. In the rat liver, the concentration of S-adenosyl-L-methionine is about 100 μ M. Galactosamine treatment reduced the high-molecular-weight S-adenosyl-L-methionine synthetase from 66.5 pmoles per min per mg protein in the control group (n = 9) to 31.4 pmoles per min per mg protein (n = 8). This reduction of the activity of the high-molecular weight S-adenosyl-L-methionine synthetase was accompanied by a reduction of the concentration of S-adenosyl-L-methionine from 111.3 ± 5.7 μ M in the control group to 56.9 ± 3.2 μ M in the group of animals treated with galactosamine. Our results support the hypothesis that in human cirrhotic liver there is a marked reduction in the rate of synthesis and utilization of S-adenosyl-L-methionine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Methionine metabolism in mammals
Finkelstein, J. D. (1990) · The Journal of Nutritional Biochemistry · doi:10.1016/0955-2863(90)90070-2 · Cited by 1,491
Selhub, J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.217 · Cited by 1,186
Role of oxidative stress in alcohol-induced liver injury
Cederbaum, A. I., Lu, Y., & Wu, D. (2009) · Archives of Toxicology · doi:10.1007/s00204-009-0432-0 · Cited by 596
S-adenosylmethionine in Liver Health, Injury, and Cancer
Lu, S. C., & Mato, J. M. (2012) · Physiological Reviews · doi:10.1152/physrev.00047.2011 · Cited by 554
Self-citationS-adenosylmethionine synthesis: Molecular mechanisms and clinical implications
Mato, J., Alvarez, L., Ortiz, P., & Pajares, M. A. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00197-0 · Cited by 488
Self-citation
Metadata
- Authors
- Cabrero, C., Duce, A. M., Ortiz, P., Alemany, S., & Mato, J. M.
- Venue
- Hepatology
- Published
- 1988-11
- Volume
- 8
- Issue
- 6
- Pages
- 1530-1534
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2128215408
- Cited by
- 164
- References
- 0
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specific loss of the high-molecular-weight form of S -adenosyl-l-methionine synthetase in human liver cirrhosis. https://app.cochat.ai/papers/10.1002/hep.1840080610
- The paper
- Cabrero, C., Duce, A. M., Ortiz, P., Alemany, S., & Mato, J. M. (1988). Specific loss of the high-molecular-weight form of S -adenosyl-l-methionine synthetase in human liver cirrhosis. Hepatology. https://doi.org/10.1002/hep.1840080610
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.